Clinical Trials Browser

Phase 2 × Radiotherapy, Image-Guided × 30 days × Clear all

NCT06499870 2026-06-05

Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial

Phase 2 Recruiting

Prostate Adenocarcinoma